The leading digital health startup in the Baltics, Longenesis, in collaboration with Daugavpils Regional Hospital and Novartis Baltics, has signed a Memorandum of Understanding to launch a pilot project in Latvia for the treatment and prevention of cardiovascular diseases. The project aims to create a dynamic digital registry for heart failure and dyslipidemia patients, enhancing risk group identification and enabling timely treatment. Patient enrolment is set to begin at Daugavpils Regional Hospital in early 2025.

The registry will securely collect data from multiple information systems into a regularly updated patient overview panel for doctors. This dynamic patient monitoring option will enable doctors to track changes in the patient's condition, reflecting their current risk factors, thus improving the quality and timeliness of treatment.

Cardiovascular diseases are the most common cause of death in Latvia, claiming 14,395 lives in 2023, with Latgale standing out with the proportionally highest mortality rates.

At the opening event of the pilot project, it was emphasized that a dynamic patient registry solution not only highlights the importance of innovation and digitization in healthcare, but also proves that such innovations are possible in all regions of Latvia. Longenesis, Daugavpils Regional Hospital, and Novartis Baltics are joining forces to create more effective solutions in the prevention and treatment of cardiovascular diseases, significantly improving the overall quality of healthcare in Latvia.